OLIVIA CUSUMANO: Open Payments
NPI 1306522776 · OKEMOS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,217 in 56 payments from 14 companies in 2025. Trend: 2023 $329 · 2024 $908 · 2025 $1,217
Food & beverage: $1,217
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 10 | $323 |
| ABBVIE INC. | 14 | $195 |
| Novartis Pharmaceuticals Corporation | 9 | $165 |
| Regeneron Healthcare Solutions, Inc. | 4 | $118 |
| Janssen Biotech, Inc. | 4 | $95 |
| GENZYME CORPORATION | 3 | $76 |
| LEO Pharma Inc. | 3 | $60 |
| KYOWA KIRIN, INC. | 2 | $43 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
Products named: Bimzelx, SKYRIZI, COSENTYX, DUPIXENT, TREMFYA, SPEVIGO, AYVAKIT, Rhapsido.
Industry payments across MI — which companies pay providers there.
